2019 CMHC West Accreditation
May 3-5, 2019 | Phoenix, AZ
3rd Annual CMHC West
May 3-5, 2019 | Phoenix, AZ
CMHC West is designed for US-based healthcare professionals, including primary care clinicians (PCPs), nurse practitioners (NPs), physician assistants (PAs), endocrinologists, diabetologists, pharmacists, cardiologists, lipidologists, and other allied health professionals.
STATEMENT OF NEED/PROGRAM OVERVIEW
The ever-increasing presence of cardiometabolic risk continues to be a major challenge for health care providers in the United States. Current estimates suggest approximately 23% - 38% of all U.S. adults have metabolic syndrome, a constellation of cardiometabolic risk factors, including excessive abdominal fat, insulin resistance, inflammation, dyslipidemia, and hypertension. Patients with multiple cardiometabolic risk factors have twice the likelihood of developing and dying from cardiovascular disease and more than seven times the risk of developing diabetes compared to those with no cardiometabolic risk factors. Cardiovascular disease already affects approximately 83.6 million U.S. adults (> 1 in 3) and is the leading cause of U.S. deaths; however, this CVD burden can be expected to increase.
This sampling of sobering statistics points to a rapidly growing epidemic of cardiovascular and metabolic disease and calls to the forefront the need for medical education focused on all aspects of cardiometabolic risk. The CMHC presents an especially valuable venue for this educational outreach with sessions fostering a collaborative, multidisciplinary approach to care.
The 2019 CMHC West meeting will highlight the latest updates in hypertension, heart failure, diabetes, dyslipidemia, lifestyle management, bariatric surgery, and cardiovascular health, and translate the latest cutting-edge medical research into practical, clinical strategies for preventing, delaying, and managing cardiovascular and metabolic disorders. New this year to the 2019 CMHC West meeting will be a half-day Women's Health Summit, focusing on cardiometabolic risk assessment and management in women with conditions ranging from PCOS and pregnancy to breast cancer and type 2 diabetes. This education will be delivered through thought provoking educational sessions followed by expert faculty discussions. The goal is to provide the medical community with evidence-based interventions to improve health outcomes and quality of life for the growing numbers of patients at increased cardiometabolic risk.
After completing this activity, the participant should be better able to:
Outline the efficacy and safety of lifestyle modifications, pharmacotherapy, and bariatric surgery for the comprehensive weight management in patients with cardiometabolic disease
Identify individualized treatment regimens for the management of dyslipidemia based on the latest guidelines and evidence about current and emerging agents
Describe the recent advances in antithrombotic therapy for diabetic patients with stable CAD or PAD
Interpret the latest guidelines and evidence for the management and treatment of complex patients with hypertension, heart failure, and type 2 diabetes
Select treatment regimens for type 2 diabetes that optimize glycemic control and minimize risk for complications based on specific patients’ needs and latest evidence
Identify clinical strategies to address cardiovascular concerns in breast cancer patients during the cancer treatment continuum
Review current and updated evidence-based guideline recommendations for prevention, screening, and treatment of cardiometabolic complications of PCOS and pregnancy
Recall the cardiometabolic safety of postmenopausal hormone therapy in women
Outline management strategies to address the psychological factors and medical disorders in women with diabetes
Define the nuances of CVD risk assessment and treatment for primary and secondary prevention in women
Identify individualized approaches for the management of cardiometabolic health as it relates to high-risk patient populations, PCOS, postmenopausal symptoms, contraception, and long-term pregnancy adverse outcomes
Please click here to view all faculty listings.
Please click here to view the full agenda.
JOINT ACCREDITATION STATEMENT
In support of improving patient care, this activity has been planned and implemented by the Postgraduate Institute for Medicine and CMHC. Postgraduate Institute for Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Physician Continuing Medical Education
The Postgraduate Institute for Medicine designates this live activity for a maximum of 13.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Continuing Pharmacy Education
Postgraduate Institute for Medicine designates this continuing education activity for 13.5 contact hour(s) (1.35 CEUs) of the Accreditation Council for Pharmacy Education.
This is an application-based activity. Universal Activity Number (UAN): JA4008162-9999-19-717-L01-P.
Continuing Nursing Education
The maximum number of hours awarded for this Continuing Nursing Education activity is 13.5 contact hours. Pharmacotherapy contact hours for Advanced Practice Registered Nurses will be designated on your certificate.
CONTINUING DIETICIAN education
Postgraduate Institute for Medicine (CDR Provider #3631) is a Continuing Professional Education (CPE) Accredited Provider with the Commission on Dietetic Registration (CDR). CDR Credentialed Practitioners will receive 14.0 Continuing Professional Education units (CPEUs) for completion of this activity.
This is a Level III activity.
The World Obesity/Clinical Care committee decided that the further learning value, quality and structure of the 3rd Annual CMHC West comply with Specialist Certification of Obesity Professional Education (SCOPE) principles. This event has been accredited with 4 SCOPE Points which count towards SCOPE Certification.
SCOPE Certification is conferred by the World Obesity Federation and is the internationally-recognized standard of excellence in obesity management. SCOPE Certification is awarded to health professionals with obesity management experience who have earned 12 SCOPE points.
For questions regarding SCOPE points, please contact firstname.lastname@example.org.
Disclosure of Conflicts of Interest
Postgraduate Institute for Medicine (PIM) requires instructors, planners, managers, and other individuals who are in a position to control the content of this activity to disclose any real or apparent conflict of interest (COI) they may have as related to the content of this activity. All identified COI are thoroughly vetted and resolved according to PIM policy. PIM is committed to providing its learners with high quality activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of a commercial interest.
Disclosures will be provided on the mobile app. Please check back online at a later date.
Planners and Managers
The PIM planners and managers have nothing to disclose. The CMHC planners and managers have nothing to disclose.
Disclosure of Unlabeled Use
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications. The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient's conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer's product information, and comparison with recommendations of other authorities.
Request for Credit
Learners may earn up to a maximum of 17.25 AMA/ACPE, 17.1 ANCC, or 19 CDR credit hours by attending all General Sessions and CME Satellite Symposia. Full credit information will be provided in the final conference guide.
If you wish to receive acknowledgment for completing this activity, please complete the evaluation on www.cmeuniversity.com. On the navigation menu, click on “Find Post-test/Evaluation by Course” and search by course ID 13821. Upon registering and completing the activity evaluation, your certificate will be made available immediately.
For Pharmacists: Please complete the evaluation on www.cmeuniversity.com. On the navigation menu, click on “Find Post-test/Evaluation by Course” and search by course ID 13821. Upon registering and completing the activity evaluation, your transcript information will be sent to the NABP CPE Monitor Service.
FEE INFORMATION & REFUND/CANCELLATION POLICY
There is registration fee for this educational activity, registration information can be found here.
EDUCATIONAL GRANT SUPPORT
For supported satellite symposia information, click here.